Know Cancer

forgot password

Computer-Based Comprehensive Geriatric Assessment in Oncology for Individuals 70 or Older With Colorectal, Breast or Lung Cancer

70 Years
Open (Enrolling)
Rectal Cancer, Breast Cancer, Lung Cancer

Thank you

Trial Information

Computer-Based Comprehensive Geriatric Assessment in Oncology for Individuals 70 or Older With Colorectal, Breast or Lung Cancer

- Participants will complete the geriatric assessment on the computer either at their
home via the web (if they have internet access) or in the clinic at their next visit
prior to seeing the doctor.

- All individuals will have a unique way to sign on to the computer program that protects
the information so that only the participant and the research team will be able to view
it. Individuals who require assistance to answer the questions will have help provided
by a research assistant.

- We will ask participants to complete the geriatric assessment a second time at 4 months
after they have enrolled on the study or 1 month after completing their chemotherapy
treatment, whichever occurs first.

Inclusion Criteria:

- Ability to understand and the willingness to sign a written informed consent document

- Patients with colorectal, breast or lung cancer at any stage who are under
consideration for initiation of or change in cytotoxic chemotherapy regimen.
Patients must start chemotherapy within 4 weeks of enrollment. Chemotherapy regimens
may include traditional cytotoxic therapy, oral biological agent, or combination of a
biologic therapy and cytotoxic chemotherapy.

- Patients age 70 or older at enrollment

- Patients must be able to read English and able to complete the web-based computer

Exclusion Criteria:

- Patients with a physical limitation preventing computer use (visual impairment,
inability to use computer mouse or touch screen).

- Patients who are hospitalized or enrolled in hospice

Type of Study:


Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

To determine the feasibility and added clinical utility of a self-administered computer-based version of an abbreviated comprehensive geriatric assessment tool.

Outcome Time Frame:

2 years

Safety Issue:


Principal Investigator

Nadine Jackson, MD, MPH

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dana-Farber Cancer Institute


United States: Institutional Review Board

Study ID:




Start Date:

March 2009

Completion Date:

Related Keywords:

  • Rectal Cancer
  • Breast Cancer
  • Lung Cancer
  • geriatric assessment
  • Breast Neoplasms
  • Rectal Neoplasms
  • Lung Neoplasms



Dana-Farber Cancer Institute Boston, Massachusetts  02115